New database delivers 7,500+ neuroscience drugs and 9,000+ clinical trials to help researchers and drug developers explore and understand the evolving neuroscience disease landscape.
Beacon Intelligence has launched Beacon Neuroscience, a new database designed to help researchers, analysts, and decision-makers working in neuroscience drug development.
The database brings together curated data on more than 7,500 drugs and 9,000 clinical trials, offering a clear and structured view of innovation across the central nervous system (CNS) landscape. Developed with input from the scientific community, Beacon Neuroscience has been created to make it easier for professionals to find, analyze and act on the information that matters most.
A clearer picture of neuroscience development
Neuroscience remains one of the most complex areas of biomedical research. The field covers a broad range of conditions – from neurodegenerative and neuromuscular diseases to movement, genetic and cerebrovascular disorders – all of which are covered within the Beacon Neuroscience dataset.
Neuroscience continues to evolve rapidly with advances in drug discovery and delivery technologies and Beacon Neuroscience was developed to bring greater visibility to this activity.
The database enables users to explore drug and trial data in detail, helping them to identify emerging areas of research, track the progress of specific therapies and gain a better understanding of the wider development landscape.
All data within the database is manually curated and verified by Beacon’s in-house neuroscience team, ensuring accuracy and consistency across each record. The information is updated daily so users can be confident they are working with the latest data available.
Developed with scientists, for scientists
The creation of Beacon Neuroscience was guided by detailed feedback from researchers and R&D teams. The focus throughout has been on usability and providing tools that make it easier to interrogate large datasets, while maintaining the depth and precision that neuroscience professionals need.
Using the platform, users can:
- Compare drugs, mechanisms, and targets across multiple neuroscience disease indications
- Follow clinical trial activity and results in real time
- Identify potential collaborators or licensing opportunities
- Reduce time spent collecting and verifying data manually
Beacon’s structured ontologies and advanced search filters support more consistent and meaningful analysis, helping users to uncover patterns and insights that might otherwise remain hidden within complex datasets.
Designed to inform better decisions
By bringing together reliable, structured data in one place, Beacon Neuroscience aims to support faster and more informed decision-making across the sector.
Eloise Jarvis, Lead Research Analyst at Beacon, said:
“The neuroscience field is advancing quickly, but the amount of information available can make it difficult to keep track of what’s happening. Beacon Neuroscience gives drug developers a clear, accurate view of the data behind that progress. It’s been designed to help people explore confidently and draw their own conclusions.”
Building on Beacon’s existing expertise
Beacon Neuroscience joins a portfolio of therapeutic & disease databases developed by Beacon Intelligence, including oncology, ADC, cell therapy, and RNA therapeutics. Each database is built around the same principles: high-quality curation, transparent data, and user-led design.
As neuroscience research expands into new modalities and targets, Beacon plans to continue developing the platform, adding further layers of insight, including company and commercial data, as well as adding neuropsychiatric disorders including depression, anxiety, schizophrenia, and neurodevelopmental disorders to the dataset, to ensure it remains relevant and responsive to the needs of the community.
Find out more about how Beacon Neuroscience can accelerate your Neuroscience drug development decisions.
